Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-β-cyclodextrin/drug complexes after intravenous injection into rats: Implications in drug delivery

Biochimica et Biophysica Acta - General Subjects

Volumn 1291, Issue 3, 1996, Pages 237-244

  McCormack, Brenda ^a   Gregoriadis, Gregory ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cyclodextrin; Dehydroepiandrosterone; Dexamethasone; Drug delivery; Liposome; Retinol

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; DEXAMETHASONE; DISTEAROYLPHOSPHATIDYLCHOLINE; LIPOSOME; PRASTERONE; RETINOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; COMPLEX FORMATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TISSUE LEVEL; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BETA-CYCLODEXTRINS; CYCLODEXTRINS; DEHYDROEPIANDROSTERONE; DEXAMETHASONE; DRUG CARRIERS; INJECTIONS, INTRAVENOUS; LIPOSOMES; RATS; RATS, WISTAR; VITAMIN A;

ANIMALIA;

EID: 0030573164     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(96)00096-7     Document Type: Article

References (30)

1. [1] Duchêne, D. and Wounessidjewe, D. (1993) in New Trends in Cyclodextrins and Derivatives (Duchêne, D., ed.), pp. 447-482, Editions de Santé, Paris.
2. [2] Uekama, K. and Otagiri, M. (1987) CRC Crit. Rev. Ther. Drug Carrier Syst. 38, 189-193.
3. [3] Szejtli, J., Bolla-Pusztai, E., Lengyel-Tardy, M., Szabo, P. and Ferenczy, T. (1983) Pharmazie 38, 189-193.
4. [4] Gal-Fuzy, M., Szente, L., Szejtli, J. and Harangi, J. (1985) Pharmazie 39, 558-559.
5. [5] Stadler-Szoke, A., Vikmon, M., Szejtli, J. and Kajtar, M. (1985) J. Inclusion Phenom. 3, 71-84.
6. [6] Bootsma, H.P.R., Frijlink, H.W., Eissens, A., Proost, J.H., Van Doorne, H. and Lerk, C.F. (1989) Int. J. Pharm. 51, 213-223.
7. [7] Hassan, M.A., Suleiman, M.S. and Najib, N.M. (1990) Int. J. Pharm. 58, 19-24.
8. [8] Puglisi, G., Santagati, N.A., Ventura, C.A., Pignatello, R., Panico, A.M. and Spampinato, S. (1991) Drug Dev. Ind. Pharm. 16, 395-413.
9. [9] Irie, T., Otagiri, M., Sunada, M., Uekama, K., Ohtani, Y., Yamada, Y. and Sugiyama, Y. (1982) J. Pharmacobio-Dyn. 5, 741.
10. [10] Frank, D.W., Gray, J.E. and Weaver, R.N. (1976) Am. J. Pathol. 83, 367-382.
11. [11] McCormack, B. and Gregoriadis, G. (1994) Int. J. Pharmaceut. 112, 249-258.
12. [12] McCormack, B. and Gregoriadis, G. (1994) J. Drug Targeting 2, 449-454.
13. [13] Gregoriadis, G. (1995) Trends Biotechnol. 13, 527-537.
14. [14] Kirby, C. and Gregoriadis, G. (1984) Biotechnology 2, 979-984.
15. [15] Gregoriadis, G., Garçon, N., Da Silva, H. and Sternberg, B. (1993) Biochim. Biophys. Acta 1147, 185-193.
16. [16] Gregoriadis, G. and Ryman, B.E. (1972) Biochem. J. 128, 142-143.
17. [17] Kurzmann, I.D., MacEwen, G.G. and Haffa, A.L. (1990) Int. J. Obesity 14, 95-104.
18. [18] Araneo, B.A., Woods, II M.L. and Daynes, R.A. (1993) J. Infect. Dis. 167, 830-840.
19. [19] Pitha, J. and Szente, L. (1983) Life Sci. 32, 719-723.
20. [20] Miyabo, S., Nakamura, T., Kuwazima, S. and Kishida, S. (1981) Eur. J. Clin. Pharmacol. 20, 277-282.
21. [21] Loukas, Y., Jayasekera, P. and Gregoriadis, G. (1995) J. Phys. Chem. 99, 11035-11040.
22. [22] Mesens, J.L. and Putteman, P. (1993) in New Trends in Cyclodextrins and Derivatives (Duchêne, D. ed.), pp. 369-407, Editions de Santé, Paris.
23. [23] Gregoriadis, G. and Davis, C. (1979) Biochem. Biophys. Res. Commun. 89, 1287-1293.
24. [24] Castelli, F., Puglisi, G., Giammona, G. and Ventura, C.A. (1992) Int. J. Pharm. 88, 1-8.
25. [25] Gregoriadis, G. (1995) in Stealth Liposomes (Lasic, D. and Martin, F., eds.), pp. 7-12, CRC Press, Boca Raton.
26. [26] Kirby, C. and Gregoriadis, G. (1983) Biochem. Pharmacol 32, 609-615.
27. [27] Pitha, J. (1993) in New Trends in Cyclodextrins and Derivatives (Duchêne, D., ed.), pp. 357-367, Editions de Santé, Paris.
28. [28] Frömming, K.-H. and Szejtli, J. (eds.) (1994) Cyclodextrins in Pharmacy, pp. 105-126, Kluwer, Dordrecht.
29. [29] Frijlink, H.W., Franssen, E.J.F., Eissens, A.C., Oosting, R., Lerk, C.F. and Meijer, D.K.F. (1991) Pharm. Res. 8, 380-384.
30. [30] Anderson, W., Brewster, M., Simpkine, J. and Bodor, N. (1990) Pharm. Res. 7 S226.